![]() |
PROPOSAL TO WAIVE IN VIVO BIOEQUIVALENCE REQUIREMENTS FOR THE. 138 categorizados. Incluye 25 III I). 1. Abacavir. 2. Aciclovir. 3. Atenolol. 4. The fixed-dose combination tablet of lamivudine (FDC) has been shown to be bioequivalent to lamivudine and abacavir administered separately. new/5018-1-16409.php The objective of the current study was to determine the bioequivalence between a generic formulation of abacavir and the innovator product.MATERIAL AND. new/3554-1-8707.php Therapeutic Category ||||||
Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|